Mortality of Sepsis in Swedish Intensive Care Units 2008-2016

April 4, 2018 updated by: Uppsala University
A study of short and long term mortality in patients treated with or without a diagnosis of sepsis in Swedish intensive care units (ICU) 2008 - 2016. The cohort is characterized with regard to chronic comorbidity, severity of acute illness and demographic factors, and outcome is adjusted for these factors. Changes in mortality during the period are studied.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

All adult patients admitted to a general ICU included in the Swedish Intensive Care Registry (a majority of all ICUs in Sweden) between 2008-01-01 and 2016-10-18 are followed for one year and any deaths are registered. Data on illness severity scores, age, sex, admitting hospital and duration of ICU stay are recovered. Data are linked with the inpatient registry of the Swedish Board of Health and Welfare (Socialstyrelsen), and any discharge diagnoses from the last 5 years preceding ICU admission are recovered. These are used to assess chronic comorbidity.

Mortality, adjusted for severity of illness, comorbidity and patient factors, is studied and any changes over time during the inclusion period are assessed.

The data in the Swedish ICU Registry are entered by the treating ICU physicians and include severity of illness (Simplified Acute Physiology Score (SAPS)3), selected chronic comorbidity, sex and date of birth, ICU stay and selected interventions and complications. Relevant International Classification of Diseases (ICD)-10 diagnoses are required and assessment of the occurrence of severe sepsis or septic shock, during the inclusion period defined according to the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) (sepsis 2) criteria, is mandatory when entering data.

Study Type

Observational

Enrollment (Actual)

252245

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adult general ICU patients included in the Swedish Intensive Care Registry 2008-01-01 to 2016-10-18.

Description

Inclusion Criteria:

  • Admission to a Swedish general ICU (excluding specialized cardiothoracic, neurosurgical, pediatric and burns units) between 2008-01-01 and 2016-10-18
  • Episode registered in Swedish Intensive Care Registry

Exclusion Criteria:

  • Age < 18 years
  • Readmission (only first episode during the period included)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sepsis group
All adult (>= 18 years) patients with a diagnosis of sepsis included in the Swedish ICU Registry between 2008-01-01 and 2016-10-18
exposure to ICU treatment with or without diagnosed sepsis
Non-sepsis group
All adult (>=18 years) patients without a diagnosis of sepsis included in the Swedish ICU Registry between 2008-01-01 and 2016-10-18
exposure to ICU treatment with or without diagnosed sepsis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 day mortality
Time Frame: From the day of ICU admission until death of any cause , whichever came first, assessed up to 30 days.
mortality within 30 days after admission to ICU
From the day of ICU admission until death of any cause , whichever came first, assessed up to 30 days.
90 day mortality
Time Frame: From the day of ICU admission until death of any cause, whichever came first, assessed up to day 90.
mortality within 90 days after admission to ICU
From the day of ICU admission until death of any cause, whichever came first, assessed up to day 90.
365 day mortality
Time Frame: From the day of ICU admission until death of any cause , whichever came first, assessed up to day 365.
mortality within 365 days after admission to ICU
From the day of ICU admission until death of any cause , whichever came first, assessed up to day 365.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hospital mortality
Time Frame: From the day of ICU admission until death of any cause or day of hospital discharge, whichever came first, assessed up to day 365.
mortality before discharge from hospital after admission to ICU
From the day of ICU admission until death of any cause or day of hospital discharge, whichever came first, assessed up to day 365.
ICU length of stay
Time Frame: From the day of ICU admission until death of any cause or day of ICU discharge, whichever came first, assessed up to day 365.
From the day of ICU admission until death of any cause or day of ICU discharge, whichever came first, assessed up to day 365.
hospital length of stay
Time Frame: From the day of ICU admission until death of any cause or day of hospital discharge , whichever came first, assessed up to day 365.
From the day of ICU admission until death of any cause or day of hospital discharge , whichever came first, assessed up to day 365.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2008

Primary Completion (ACTUAL)

October 25, 2017

Study Completion (ACTUAL)

October 25, 2017

Study Registration Dates

First Submitted

March 21, 2018

First Submitted That Met QC Criteria

April 4, 2018

First Posted (ACTUAL)

April 5, 2018

Study Record Updates

Last Update Posted (ACTUAL)

April 5, 2018

Last Update Submitted That Met QC Criteria

April 4, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2015/519

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on ICU care

3
Subscribe